Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling: Implications for cancer therapy

Journal of Experimental Medicine

Volumn 191, Issue 1, 2000, Pages 195-200

  Newton, Kim ^a   Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bcl 2; Caspases; Death receptors; Fas APO 1 CD95; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CHEMOTHERAPY; CELL KILLING; CLONOGENESIS; CONTROLLED STUDY; GAMMA RADIATION; IONIZING RADIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARABIDOPSIS PROTEINS; FATTY ACID DESATURASES; LYMPHOCYTES; MICE; MICE, INBRED C57BL; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034598365     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.1.195     Document Type: Article

References (40)

1. Ashkenazi, A., and V.M. Dixit. 1998. Death receptors: signaling and modulation. Science. 291:1305-1308.
2. Friesen, C., I. Herr, P.H. Krammer, and K.-M. Debatin. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2:574-577.
3. Srivastava, R.K., C.Y. Sasaki, J.M. Hardwick, and D.L. Longo. 1999. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J. Exp. Med. 190:253-266.
4. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D.R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell. 1:543-551.
5. Micheau, O., E. Solary, A. Hammann, and M.-T. Dimanche-Boitrel. 1999. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274:7987-7992.
6. Eischen, C.M., T.J. Kottke, L.M. Martins, G.S. Basi, J.S. Tung, W.C. Earnshaw, P.J. Leibson, and S.H. Kaufmann. 1997. Comparison of apoptosis in wild-type and Fas-resistant cells - chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90:935-943.
7. Gamen, S., A. Anel, P. Lasierra, M.A. Alava, M.J. Martinez-Lorenzo, A. Pineiro, and J. Naval. 1997. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 417:360-364.
8. Villunger, A., A. Egle, M. Kos, B.L. Hartmann, S. Geley, R. Kotler, and R. Greil. 1997. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res. 57:3331-3334.
9. Kataoka, T., M. Schroter, M. Hahne, P. Schneider, M. Irmler, M. Thome, C.J. Froelich, and J. Tschopp. 1998. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J. Immunol. 161:3936-3942.
10. McGahon, A.J., A.P. Costa Pereira, L. Daly, and T.G. Cotter. 1998. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/ CD95) receptor/ligand system. Br. J. Haematol. 101:539-547.
11. Tolomeo, M., L. Dusonchet, M. Meli, S. Grimaudo, N. D'Alessandro, G. Papoff, G. Ruberti, and L. Rausa. 1998. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Cell Death Differ. 5:735-742.
12. Ruiz-Ruiz, M.C., and A. López-Rivas. 1999. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Cell Death Differ. 6:271-280.
13. Richardson, D.S., P.D. Allen, S.M. Kelsey, and A.C. Newland. 1999. Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells. Adv. Exp. Med. Biol. 457:259-266.
14. Landowski, T.H., K.H. Shain, M.M. Oshiro, I. Buyuksal, J.S. Painter, and W.S. Dalton. 1999. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation. Blood. 94:265-274.
15. Strasser, A., A.W. Harris, M.L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:331-333.
16. McDonnell, T.J., and S.J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 349:254-256.
17. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149-1154.
18. Davidson, W.F., T. Giese, and T.N. Fredrickson. 1998. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J. Exp. Med. 187:1825-1838.
19. Newton, K., A.W. Harris, M.L. Bath, K.G.C. Smith, and A. Strasser. 1998. A dominant interfering mutant of FADD/ Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 17:706-718.
20. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
21. Cohen, P.L., and R.A. Eisenberg. 1993. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today. 13:427-428.
22. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:847-849.
23. Schneider, P., N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213.
24. Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:329-339.
25. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:849-852.
26. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:957-967.
27. Strasser, A., A.W. Harris, D.C.S. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 14:6136-6147.
28. Van Parijs, L., A. Biuckians, and A.K. Abbas. 1998. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 160:2065-2071.
29. Müller, M., S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S.L. Friedman, P.R. Galle, W. Stremmel, M. Oren, et al. 1998. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188:2033-2045.
30. Yeh, W.C., J.L. Pompa, M.E. McCurrach, H.B. Shu, A.J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1954-1958.
31. Varfolomeev, E.E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J.S. Beckmann, I.L. Mett, D. Rebrikov, V.M. Brodianski, O.C. Kemper, O. Kollet, et al. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:267-276.
32. Soengas, M.S., R.M. Alarcón, H. Yoshida, A.J. Giaccia, R. Hakem, T.W. Mak, and S.W. Lowe. 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:156-159.
33. Gecconi, F., G. Alvarez-Bolado, B.I. Meyer, K.A. Roth, and P. Gruss. 1998. Apaf-1 (CED-4 homologue) regulates programmed cell death in mammalian development. Cell. 94:727-737.
34. Yoshida, H., Y.-Y. Kong, R. Yoshida, A.J. Elia, A. Hakem, R. Hakem, J.M. Penninger, and T.W. Mak. 1998. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 94:739-750.
35. Hakem, R., A. Hakem, G.S. Duncan, J.T. Henderson, M. Woo, M.S. Soengas, A. Elia, J.L. de la Pompa, D. Kagi, W. Khoo, et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:339-352.
36. Kuida, K., T.F. Haydar, C.-Y. Kuan, Y. Gu, C. Taya, H. Karasuyama, M.S.-S. Su, P. Rakic, and R.A. Flavell. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:325-337.
37. Gong, J.-G., A. Costanzo, H.-Q. Yang, G. Melino, W.G. Kaelin, Jr., M. Levrero, and J.Y.J. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:806-809.
38. Agami, R., G. Blandino, M. Oren, and Y. Shaul. 1999. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature. 399:809-813.
39. Yuan, Z.-M., H. Shioya, T. Ishiko, X. Sun, J. Gu, Y.Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 399:814-817.
40. Brown, J.M., and B.G. Wouters. 1999. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59: 1391-1399.